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ABSTRACT We have cloned and identified the major
cuticular glycoprotein (gp29) of lymphatic Mrarial nematode
parasites as a homolog of the antioxidant enzyme glutathione
peroxidase. The derived amino acid sequence predicted a
protein of 25.8 kDa, with an amino-terminal hydrophobic
signal peptide and two sites for N-linked glycosylation, consis-
tent with the documented properties of gp29. Transcription of
a full-length cDNA in an SP65 vector and subsequent transla-
tion of the RNA in reticulocyte lysates in vitro generated a
protein of 27 kDa, which was glycosylated upon the addition of
pancreatic microsomal membranes. A postulated role for this
secreted enzyme could be inhibition of the oxidative burst of
leukocytes and neutralization of secondary products of lipid
peroxidation, thus providing one explanation for the resistance
of these parasites to immune effector mechanisms and their
persistence in the mammalian host.
Lymphatic filariasis is a serious debilitating disease that
affects some 90 million people worldwide (1). The causative
agents, filarial nematodes of the genera Brugia and Wuchere-
ria, are parasites that persist for long periods of time in the
human lymphatic system. They achieve this longevity despite
a vigorous host immune response and their apparent inability
to undergo antigenic variation, implying a sustained resis-
tance to or subversion of host immunity.
All nematodes are bounded by a cuticle, an extracellular
matrix composed predominantly of collagens, and a highly
cross-linked external envelope of proteins termed cuticlin (2,
3). In contrast to these conserved structural elements, the
nematode cuticle exhibits an extremely restricted profile of
soluble constituent proteins that may be species- or stage-
specific (3, 4). The major protein of adult lymphatic filarial
parasites defined by surface labeling is a 29-kDa glycoprotein
(gp29) that appears to be expressed after infection of the
mammalian host (5-11). Peptide mapping has shown that
gp29 from Brugia pahangi and Brugia malayi are highly
homologous (8), and the 29-kDa surface-labeled protein from
Brugia timori (5) and Wuchereria bancrofti (6) probably
represents the same molecule. In adult B. malayi gp29 is
synthesized in the syncytial hypodermis, exported to the
cuticle, and released into the external environment during in
vitro culture (9, 10).
We report here the isolation and sequence of cDNAs that
encode gp29 from B. pahangi,t which reveals that this
cuticular protein is a homolog of the antioxidant enzyme
glutathione peroxidase (GSHPx). A possible biological role
for this enzyme in defense against immune-mediated cyto-
toxicity is discussed.
MATERIALS AND METHODS
Parasites. B. malayi were obtained from TRS laboratories,
Athens, GA. Adult worms were recovered from the perito-
neal cavities ofjirds (Meriones unguiculatus) infected over 3
mo previously with 200 infective larvae and washed exten-
sively with phosphate-buffered saline.
Labeling Procedures and Immunochemical Analysis. Adult
B. malayi (mixed sex) were extrinsically labeled with Bolton-
Hunter reagent and Iodo-Gen as described elsewhere (12).
Parasites were also metabolically labeled with sodium
[5S]selenite at 0.25 mCi ml-1 (Amersham SCS-1; 1 Ci = 37
GBq) via in vitro culture for 24 hr in RPMI 1640 medium/2
mM glutamine/1% glucose/penicillin at 100 units-ml-'/
streptomycin at 100 ,ugml-1. All labeled preparations were
homogenized in phosphate-buffered saline/1.5% 1-octyl glu-
coside containing a mixture of protease inhibitors (12) and
then centrifuged at 11,000 x g. Immunoprecipitation assays
were done with 2.5 ,ul of antiserum in a total volume of 50 ,ul
as described (12), resolved on 7-25% gradient polyacrylam-
ide gels, and autoradiographed.
cDNA Isolation, Confirmation, and Sequence Determina-
tion. A cDNA library in bacteriophage Agtll constructed
from mRNA of mixed adult B. pahangi (13) was screened
with a polyclonal antiserum to gp29 (9). Clones that reacted
positively against gp29 in immunoprecipitation assays after
affinity purification of antibody on plaque lysates (12) were
selected for further analysis. cDNA 29.2 was excised from
Agtll with EcoRI and subcloned into pGEX-1 (14). The
resultant protein, fused to glutathione S-transferase (GST),
was expressed in Escherichia coli TG2 cells as described (14)
and purified by preparative SDS/PAGE and electroelution.
An antiserum was raised to the GST/29.2 fusion protein in a
rabbit by a standard protocol and used in immunoprecipita-
tion assays to confirm that the cDNA encoded gp29. Both
cDNAs were subcloned into M13 vectors and sequenced on
both strands via standard protocols of dideoxynucleotide
chain termination.
Transcription and Translation in Vitro. The full-length
cDNA (29.1) was excised from Agtll with EcoRI and sub-
cloned directly into pSP65 (15). TheDNA template (5 ,ug) was
transcribed with 10 units of SP6 polymerase (Boehringer
Mannheim) in the presence ofNTPs (each at 500 ,uM) at 40°C
for 1 hr. The resultant RNA (0.5 ,ug) was translated in 20 ,ul
of rabbit reticulocyte lysate (Amersham) with 100 ,uCi of
[35S]methionine for 1 hr at 30°C. Where indicated, 15 1.l of
canine microsomal membranes (Amersham) was added, and
the reaction was done at 37°C for 1 hr. Products were digested
Abbreviations: GSHPx, glutathione peroxidase; GST, glutathione
S-transferase.
*To whom reprint requests should be addressed.
tThe sequence reported in this paper has been deposited in the
GenBank data base (accession no. X63365).
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with 6 units of N-glycanase (Genzyme) at 37°C for 16 hr as
described (12).
RESULTS
Isolation ofcDNA Clones. Approximately 105 cDNA clones
were screened with a polyclonal antibody to gp29 (9), and 20
positives were plaque-purified. Of these clones, two cDNAs
(29.1 and 29.2) elicited reactivity against gp29 in immuno-
precipitation assays with antiserum that had been affinity
purified on plaque lysates (data not shown). Verification that
these cDNAs coded for gp29 was obtained by raising anti-
serum to the protein product expressed in E. coli. Thus, the
cDNA insert of 29.2 was subcloned into pGEX-1 (see Ma-
terials and Methods), and a rabbit was immunized with the
resultant fusion protein. This antibody specifically immuno-
precipitated gp29 from adult worms that had been extrinsi-
cally labeled with iodine via either Bolton-Hunter reagent or
an lodo-Gen-catalyzed reaction (Fig. 1). Gp29 is the predom-
inant protein labeled by the latter method (Fig. 1, IOD),
whereas Bolton-Hunter reagent-mediated labeling is more
pervasive (lane 1, BH). Control precipitations with the pre-
bleed serum were negative (data not shown).
Properties of the Derived Protein Sequence. The nucleotide
sequence of two overlapping cDNAs is shown in Fig. 2. The
derived amino acid sequence predicts a protein with a mass
of 25.8 kDa, two potential sites for N-linked glycosylation,
and an amino-terminal hydrophobic stretch of20 amino acids
indicative of a signal peptide. A second substantial hydro-
phobic region exists from residues 65 to 79, but this does not
show amphipathicity and is unlikely to represent a trans-
membrane segment. These data are consistent with the
known properties of gp29-namely, (i) the native protein
possesses two N-linked oligosaccharides, each with a relative
mass of 2 kDa (8) and (ii) immunoelectron microscopic
studies suggest that the protein is secreted from the under-
lying hypodermis (9, 10), and one would thus expect an
appropriate signal peptide to be encoded.
The gp29 protein sequence was used to search the National
Biomedical Research Foundation Genetics Computer Group
data bases, and considerable similarity was observed to
mammalian GSHPxs from diverse sources. Fig. 3 illustrates
the homology of gp29 to GSHPxs from human liver and
plasma (17, 18). A high degree ofamino acid identity was seen
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FIG. 1. Immunoprecipitation of gp29 from B. malayi. Lanes: 1,
complete profile of proteins in adult parasites labeled with Bolton-
Hunter reagent (BH), lodo-Gen (IOD), and selenite (SE); 2, products
of immunoprecipitation with a rabbit antiserum to a fusion protein
expressed from cDNA 29.2. Proteins were resolved on a 7-25%
gradient SDS/polyacrylamide gel; molecular size markers are given
in kDa.
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FIG. 2. Nucleotide and derived amino acid sequence of cDNAs
encoding gp29. (a) Composite sequence of cDNA 29.1 (residue
1-684) and 29.2 (residue 478-795), determined by the dideoxynucle-
otide chain-termination method on both strands after subcloning into
M13. Potential sites of N-linked glycosylation are underlined (-),
and the polyadenylylation signal sequence AATAAA is also indi-
cated (--- ). The arrow marks a possible site for signal peptidase
cleavage based on analysis of secretory proteins (16), and the
position ofthe highly conserved selenocysteine ofGSHPxs is boxed.
(b) cDNA sequence around the site encoding selenocysteine. The
UGC codon denoting cysteine is boxed.
to each enzyme (42% and 37%, respectively), although gp29
most closely resembles the plasma form in possessing an
amino-terminal leader sequence. GSHPxs from plasma and
erythrocyte cytosol exist in a tetrameric configuration (20),
and some evidence suggests that gp29 from B. pahangi also
adopts a tetrameric state (10).
The most significant difference between gp29 and mam-
malian GSHPxs lies in the codon that determines incorpo-
ration of the active-site selenocysteine in the latter enzymes
(Figs. 2 and 3). In all selenoenzymes examined to date,
selenocysteine is encoded by an in-frame UGA opal nonsense
codon (21). In the cDNA for B. pahangi gp29, this UGA is
substituted by UGC (Fig. 2a), a codon recognized by cys-
teinyl-tRNAs. Fig. 2b shows that this result is not from an
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FIG. 3. (a) Alignment of the deduced amino acid sequence of gp29 from B. pahangi (B) with that ofGSHPx from human liver (HL) (17) and
plasma (HP) (18). Residues identical to the parasite sequence are boxed, and the position of the active site selenocysteine in the human GSHPx
is marked with a star. (b) Hopp-Woods hydrophilicity plot (19) of gp29, determined in the Macintosh DNA INSPECTOR program and averaged
over six residues.
error in interpretation of the sequencing gels. Moreover, we
have isolated and sequenced the gp29 gene from genomic
DNA of B. pahangi, B. malayi, and W. bancrofti, and they
all show a UGC codon at this position (E.C. and M.E.S.,
unpublished data).
Selenium could be incorporated into gp29 by metabolic
labeling of adult B. malayi with sodium [75S]selenite over a
24-hr period of in vitro culture (Fig. 1). This result is not
unambiguous, and additional experiments are required to
determine definitively whether or not gp29 is a true selenoen-
zyme.
Transcription and Translation of cDNAs. To confirm that
the cDNAs isolated for gp29 were representative of a secre-
tory glycoprotein we subcloned clone Bp29.1 into the RNA
expression vector pSP65 (15) and translated the derived
transcript in a rabbit reticulocyte lysate with or without
microsomal membranes. Fig. 4 shows that a protein with an
estimated mass of 27 kDa was synthesized, and on addition
of the microsomal membranes, a number of higher-
molecular-size products were resolved. These products were
removed by digestion with N-glycanase, producing an addi-
tional product of 25 kDa (Fig. 4). These data indicate that
cDNA Bp29.1 encodes a protein that possesses a functional
signal peptide that mediates translocation into the endoplas-
mic reticulum, followed by N-linked glycosylation. Thus
gp29 appears to be processed like any standard secreted
glycoprotein.
RNA
Membranes
N-glycanase
DISCUSSION
GSHPxs catalyze the reduction of hydroperoxides and are
believed to protect membranes and other cellular compo-
nents from oxidative damage (22). One obvious role for such
an enzyme in helminth parasites would be defense against
antibody-dependent cellular cytotoxicity directed by host
leukocytes (23). This defense could be effected either di-
rectly, via removal of hydrogen peroxide generated by the
cellular "respiratory burst," or secondarily by conversion of
peroxidized fatty acids to their corresponding alcohols, thus
limiting the chain reaction of lipid peroxidation. Relatively
little is known about the in vivo mechanisms of immune-
mediated killing of parasitic nematodes. Microfilariae (first-
stage larvae of filarial nematodes) are susceptible to killing in
vitro either via antibody-dependent cellular cytotoxicity or
the direct application of isolated effector substances (23). In
these assays, hydrogen peroxide proved the most toxic
oxygen species toward microfilariae of Onchocerca cervica-
lis (24) and Dirofilaria immitis (25). In experiments on B.
malayi microfilariae with purified eosinophil granule pro-
teins, the most potent toxin on a molar basis was eosinophil
peroxidase in conjunction with a hydrogen peroxide-
generating system and a halide [i.e., a system capable of
generating hypohalous acids (26)]. An active GSHPx that is
secreted constitutively through the cuticle might, thus, help
to protect the parasite against this form of immune attack.
+ +
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FIG. 4. In vitro translation of gp29. Translation products from a rabbit reticulocyte lysate resolved on a 15% SDS/polyacrylamide gel are
shown with (+) or without (-) RNA and canine pancreatic microsomal membranes and after digestion with N-glycanase. Molecular sizes are
given in kDa.
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Consistent with this potential role, gp29 is expressed at
negligible levels in mosquito-derived infective larvae, but
after infection of the mammalian host, its synthesis is up-
regulated, and the molecule is transported to the cuticle (11).
Recently, GSTs have been identified and cloned from
Schistosoma japonicum (27) and Schistosoma mansoni (28,
29), trematode parasites of man. In the latter case, the
enzyme is localized in the external tegument (29), and im-
munization of rats and mice with recombinant constructs
results in a significant level of protection against challenge
infection (28). GSTs could provide a "second-line" defense
against oxidative attack via conjugation of electrophiles to
glutathione and reduction of lipid hydroperoxides (22). Ex-
posure of adult S. mansoni to glutathione-depleting agents
renders them susceptible to killing by hydrogen peroxide
(30), lending support to the concept of a protective role for
GST and GSHPx.
The selenocysteine residue in GSHPxs is critical for the
redox properties of the enzyme. Although the details of
catalysis are not completely defined, the most probable
reaction mechanism is a ping-pong process involving an
initial oxidation of the enzyme followed by a two-step re-
duction of the oxidized enzyme by glutathione (31). Indeed,
all selenoproteins that have a known function catalyze oxi-
dation-reduction reactions (32). A suppressor tRNA charged
with serine serves as the start-point for selenium biosynthesis
in prokaryotes (33) and eukaryotes (34), although the reaction
sequence may differ, as does the mRNA context required for
suppression of termination (35, 36). If gp29 is a selenium-
independent GSHPx, one would expect the velocity con-
stants for the reaction with peroxides to be drastically
reduced over an enzyme with a functional selenocysteine.
Mutation of the selenocysteine of E. coli formate dehydrog-
enase to a cysteine reduced the catalytic efficiency of the
enzyme by -380-fold (37). A similar substitution in type 1
iodothyronine deiodinase from rats resulted in a protein with
10-20%6 ofthe activity of the wild-type enzyme (38), although
a natural variant (type 11 iodothyronine deiodinase) exists
that appears to possess cysteine in the catalytic site (39). The
reason for the existence ofa selenium-independent GSHPx in
the cuticle of filarial parasites would, thus, be unclear, given
the functional advantage of a selenol group over a thiol in
terms of nucleophilic nature and catalytic potential.
An alternative possibility is that selenocysteine is formed
posttranslationally in filariae. At first sight, the incorporation
of radiolabeled selenite into gp29 shown in Fig. 1 suggests
that this formation might be possible, but the chemical
identity of the selenium moiety in the protein and the spec-
ificity of incorporation (there are four cysteine residues in the
predicted sequence) is as yet unclear. Posttranslational for-
mation would be extremely unusual, given that UGA codes
for selenocysteine in all three lineages (eubacteria, archae-
bacteria, and eukaryotes) (21). It is thus essential to deter-
mine the selenium content of native gp29 purified from
parasite material and ideally sequence derivatized protein to
resolve this paradox. With such limiting biological material,
the latter task is quite formidable.
There are other possible functions for cuticular peroxi-
dases in nematodes. One would be to catalyze the formation
of cross-linking residues, such as dityrosine, trityrosine, and
isotrityrosine, which have been identified in cuticular colla-
gen and "cuticlin," a protein complex that forms the epicu-
ticle, the structural external cortex of the cuticle (40, 41). The
temporal expression of gp29 coincides with a dramatic
growth phase in the life of the parasite, and an increased level
of cross-linking of collagens and cuticlins may be necessary
to maintain the high tensile strength of the cuticle. This
postulated function may not be mutually exclusive with an
antioxidant activity, however, and a highly cross-linked
external cortex may also serve to protect the parasite from
immune attack.
Helminth parasites must survive for extended periods of
time in their definitive host to ensure propagation of the next
generation. In the absence of the capacity for antigenic
variation, down-regulation or neutralization of the immune
response most probably plays an essential role in parasite
survival. Investigation of these defense mechanisms may
reveal attractive targets for chemo- and immuno-prophy-
laxis.
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